• Leprosy drug holds promise as at-home treatment for COVID-19 worldpharmanews
    March 19, 2021
    A Nature study authored by scientists at Sanford Burnham Prebys Medical Discovery Institute and the University of Hong Kong, S.A.R., China shows that the leprosy drug clofazimine, which is FDA approved and on the World Health Organization's List of ...
PharmaSources Customer Service